SHL Telemedicine Ltd. - ADR - New
SHLT
Get informed when a big investor buys or sells
+ FollowMarket Cap$33.6M
Close$
$-1.31
163.7% downside
Current Fair Value
163.7% downsideOvervalued by 163.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $33.60 Million |
|---|---|
| Enterprise Value | $32.08 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.71 |
| Beta | 0.29 |
| Outstanding Shares | 16,391,000 |
Return
| Return on Equity | -100.28% |
|---|---|
| Return on Assets | -51.95% |
| Return on Invested Capital | -51.72% |
Valuation & Multiples
| P/E Ratio | -1.2 |
|---|---|
| PEG | 10.9 |
| Price to Sales | 0.29 |
| Price to Book Ratio | 1.03 |
| Enterprise Value to Revenue | 0.27 |
| Enterprise Value to EBIT | -1.13 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About SHL Telemedicine International Ltd
526 employees
CEO: David Arnon SHL Telemedicine Ltd., founded in 1987 and headquartered in Tel Aviv, Israel, is a leading innovator in the development and global distribution of personal telemedicine solutions, serving markets across Israel, Europe, and beyond. The co...